AVENTIS INC 4
4 · INTROGEN THERAPEUTICS INC · Filed Sep 24, 2003
Insider Transaction Report
Form 4
AVENTIS INC
Other
Transactions
- Sale
Common Stock
2003-09-22$10.76/sh−33,450$359,922→ 2,736,643 total(indirect: 1) - Sale
Common Stock
2003-09-23$10.76/sh−34,700$373,372→ 2,701,943 total(indirect: 1)
Footnotes (1)
- [F1]Owned directly by Aventis Holdings Inc. and beneficially owned by Aventis Inc.